1.675
price down icon0.59%   -0.025
 
loading
前日終値:
$1.70
開ける:
$1.7
24時間の取引高:
1.43M
Relative Volume:
0.10
時価総額:
$1.11B
収益:
$29.48M
当期純損益:
$-201.19M
株価収益率:
-5.2344
EPS:
-0.32
ネットキャッシュフロー:
$-216.50M
1週間 パフォーマンス:
-0.59%
1か月 パフォーマンス:
+4.97%
6か月 パフォーマンス:
-61.85%
1年 パフォーマンス:
-48.79%
1日の値動き範囲:
Value
$1.67
$1.7151
1週間の範囲:
Value
$1.65
$1.89
52週間の値動き範囲:
Value
$1.4601
$5.34

Geron Corp Stock (GERN) Company Profile

Name
名前
Geron Corp
Name
セクター
Healthcare (1165)
Name
電話
(650) 473-7700
Name
住所
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
GERN's Discussions on Twitter

GERN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GERN
Geron Corp
1.675 1.11B 29.48M -201.19M -216.50M -0.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
503.52 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
641.90 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
588.05 35.74B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
271.70 35.58B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.85 27.23B 3.81B -644.79M -669.77M -6.24

Geron Corp Stock (GERN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-27 ダウングレード B. Riley Securities Buy → Neutral
2025-02-26 ダウングレード H.C. Wainwright Buy → Neutral
2024-11-05 開始されました H.C. Wainwright Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-09-09 開始されました Leerink Partners Outperform
2024-04-30 ダウングレード Robert W. Baird Outperform → Neutral
2024-04-29 開始されました TD Cowen Buy
2024-03-15 繰り返されました Needham Buy
2023-09-12 アップグレード Goldman Neutral → Buy
2023-03-28 開始されました Goldman Neutral
2022-10-28 開始されました Wedbush Outperform
2022-07-28 再開されました B. Riley Securities Buy
2021-11-02 開始されました Robert W. Baird Outperform
2021-02-18 再開されました B. Riley Securities Buy
2020-08-03 開始されました Stifel Buy
2019-11-19 再開されました B. Riley FBR Buy
2019-09-03 開始されました H.C. Wainwright Buy
2019-08-15 開始されました Cantor Fitzgerald Overweight
2019-04-09 アップグレード Needham Hold → Buy
2019-01-31 アップグレード B. Riley FBR Neutral → Buy
2018-10-02 ダウングレード B. Riley FBR Buy → Neutral
2018-07-05 開始されました B. Riley FBR, Inc. Buy
2016-09-13 繰り返されました FBR & Co. Outperform
2016-09-13 繰り返されました FBR Capital Outperform
2015-12-07 繰り返されました Piper Jaffray Overweight
2015-04-21 開始されました Oppenheimer Outperform
2014-06-12 アップグレード MLV & Co Hold → Buy
2014-03-12 ダウングレード MLV & Co Buy → Hold
2013-12-10 繰り返されました MLV & Co Buy
2013-12-10 アップグレード Needham Hold → Buy
2013-11-08 繰り返されました MLV & Co Buy
2013-10-16 開始されました MLV & Co Buy
2012-08-30 開始されました Stifel Nicolaus Buy
2012-06-28 開始されました Needham Hold
すべてを表示

Geron Corp (GERN) 最新ニュース

pulisher
09:50 AM

GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

09:50 AM
pulisher
09:23 AM

GERN Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN)Contact Kessler Topaz Meltzer & Check, LLP - Business Wire

09:23 AM
pulisher
Mar 25, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against XPLR, Geron, enCore, and TFI and Encourages Investors to Contact the Firm - TradingView

Mar 25, 2025
pulisher
Mar 25, 2025

Deep Track Capital, LP's Strategic Acquisition of Geron Corp Shares - GuruFocus.com

Mar 25, 2025
pulisher
Mar 25, 2025

Is Geron Corporation (NASDAQ:GERN) The Top Penny Stock That Will Skyrocket? - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Top 10 Penny Stocks That Will Skyrocket - Insider Monkey

Mar 25, 2025
pulisher
Mar 25, 2025

GERN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

Mar 25, 2025
pulisher
Mar 24, 2025

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GERN - GlobeNewswire Inc.

Mar 24, 2025
pulisher
Mar 24, 2025

Class Action Filed Against Geron Corporation (GERN) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire

Mar 24, 2025
pulisher
Mar 22, 2025

GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Eastern Progress Online

Mar 22, 2025
pulisher
Mar 21, 2025

GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times

Mar 21, 2025
pulisher
Mar 21, 2025

Indo-Asian News Service - IANS India Pvt Ltd

Mar 21, 2025
pulisher
Mar 21, 2025

Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025GERN - PR Newswire

Mar 21, 2025
pulisher
Mar 21, 2025

Geron Corporation Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 12, 2025 to Discuss Your RightsGERN - PR Newswire

Mar 21, 2025
pulisher
Mar 19, 2025

Geron reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 19, 2025 at 04:43 pm EDT - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Mar 19, 2025
pulisher
Mar 18, 2025

Is Geron (GERN) Among the Most Oversold Penny Stocks to Buy According to Analysts? - Insider Monkey

Mar 18, 2025
pulisher
Mar 17, 2025

Geron Corp: How Concerned Should We Be About Rytelo Sales? (NASDAQ:GERN) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 16, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron - Markets Insider

Mar 16, 2025
pulisher
Mar 15, 2025

10 Most Oversold Penny Stocks to Buy According to Analysts - Insider Monkey

Mar 15, 2025
pulisher
Mar 14, 2025

Rosen Law Firm Urges Geron Corporation (NASDAQ: GERN) Stockholders to Contact the Firm for Information About Their Rights - Business Wire

Mar 14, 2025
pulisher
Mar 14, 2025

GERN ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Geron Corporation Investors - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

GERN INVESTOR ALERT: Geron Corporation Investors with Substantia - GuruFocus.com

Mar 14, 2025
pulisher
Mar 14, 2025

GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve

Mar 14, 2025
pulisher
Mar 14, 2025

GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times

Mar 14, 2025
pulisher
Mar 14, 2025

HC Wainwright Reiterates Neutral Rating for Geron (NASDAQ:GERN) - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

GERN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Investor Brings Securities Class Action Against Geron Corp. (1) - Bloomberg Tax

Mar 13, 2025
pulisher
Mar 13, 2025

SBI Securities Co. Ltd. Acquires New Holdings in Geron Co. (NASDAQ:GERN) - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Geron’s SWOT analysis: biotech stock faces pivotal year for growth By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 12, 2025

Geron Corp appoints interim CEO amid leadership shuffle By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Geron Corp reveals CEO is leaving - The Pharma Letter

Mar 12, 2025
pulisher
Mar 12, 2025

H.C. Wainwright holds neutral on Geron stock post-EU approval - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

H.C. Wainwright holds neutral on Geron stock post-EU approval By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Geron’s SWOT analysis: biotech stock faces pivotal year for growth - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Geron Co. (NASDAQ:GERN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Longtime Bay Area biotech CEO abruptly steps down - The Business Journals

Mar 11, 2025
pulisher
Mar 11, 2025

Geron Announces Leadership Change with New Interim CEO - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Geron Corp appoints interim CEO amid leadership shuffle - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Geron’s RYTELO gains EC approval for certain blood cancers - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Geron announces EC approval of Rytelo - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS - Yahoo Finance

Mar 11, 2025
pulisher
Mar 11, 2025

Geron announces leadership transition, focuses on cancer drug potential - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Geron CEO Scarlett to leave company - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Geron Corporation Announces Departure Of CEO -March 11, 2025 at 04:03 pm EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Geron Reshapes Leadership After FDA Win: CEO Exits as RYTELO Launch Takes Center Stage - StockTitan

Mar 11, 2025
pulisher
Mar 10, 2025

Geron (NASDAQ:GERN) versus Dermata Therapeutics (NASDAQ:DRMA) Head-To-Head Comparison - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Insider Moves: Air Products, Inseego, Coterra, Geron, Green Thumb - TipRanks

Mar 08, 2025
pulisher
Mar 06, 2025

HC Wainwright Estimates Geron's Q1 Earnings (NASDAQ:GERN) - MarketBeat

Mar 06, 2025
pulisher
Mar 06, 2025

High Growth Tech Stocks To Watch In US March 2025 - Yahoo Finance

Mar 06, 2025

Geron Corp (GERN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Geron Corp (GERN) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
SCARLETT JOHN A
Chairman, President and CEO
Feb 27 '25
Buy
1.76
12,500
22,062
12,500
Ziegler James
EVP, Chief Commercial Officer
Feb 27 '25
Buy
1.60
100,000
160,000
100,000
GRETHLEIN ANDREW J
EVP, Chief Operating Officer
Jul 08 '24
Option Exercise
1.72
674,348
1,159,879
674,348
GRETHLEIN ANDREW J
EVP, Chief Operating Officer
Jul 08 '24
Sale
4.56
674,348
3,073,004
0
Feller Faye
EVP, Chief Medical Officer
Jun 10 '24
Option Exercise
1.19
287,900
341,693
155,400
Feller Faye
EVP, Chief Medical Officer
Jun 10 '24
Sale
4.63
287,900
1,334,129
0
Kapur Anil
EVP, Corp Strategy & CCO
Jun 10 '24
Option Exercise
1.06
421,875
447,188
421,875
Kapur Anil
EVP, Corp Strategy & CCO
Jun 10 '24
Sale
4.64
421,875
1,959,609
0
SCARLETT JOHN A
Chairman, President and CEO
Jun 04 '24
Option Exercise
2.54
600,000
1,524,000
600,000
SCARLETT JOHN A
Chairman, President and CEO
Jun 04 '24
Sale
4.00
600,000
2,400,000
600,000
$313.28
price down icon 1.66%
$78.78
price down icon 1.03%
$33.45
price down icon 0.56%
$20.88
price up icon 4.32%
$97.00
price up icon 0.15%
biotechnology ONC
$251.50
price down icon 0.62%
大文字化:     |  ボリューム (24 時間):